Situating the Trovan Trial With the Use of Experimental Ebola Therapies Is Like Comparing an Apple With an Orange

This is a preview of subscription content, access via your institution.

References

  1. Adebamowo, C., O. Bah-Sow, F. Binka, et al. 2014. Randomised controlled trials for Ebola: Practical and ethical issues. The Lancet 384(9952): 1423–1424.

    Article  Google Scholar 

  2. Folayan, M., B. Brown, A. Yakubu, K. Peterson, and B. Haire. 2014. Compassionate use of experimental drugs in the Ebola outbreak. The Lancet 384(9957): 1843–1844.

    Article  Google Scholar 

  3. Hossain, M.J., A. Roca, G.A. Mackenzie, et al. 2013. Serogroup W135 meningococcal disease, The Gambia, 2012. Emerging Infectious Diseases 19(9): 1507–1510.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Kanapathipillai, R., A.M.H. Restrepo, P. Fast, et al. 2014. Ebola vaccine—an urgent international priority. The New England Journal of Medicine 371(24): 2249–2251. doi:10.1056/NEJMp1412166.

    Article  PubMed  Google Scholar 

  5. Lenzer, J. 2006. Secret report surfaces showing that Pfizer was at fault in Nigerian drug tests. BMJ 332(7552): 1233.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Lenzer, J. 2011. Pfizer settles with victims of Nigerian drug trial. BMJ 343: d5268. doi:10.1136/bmj.d5268.

    Article  PubMed  Google Scholar 

  7. Maurice, J. 2014. WHO meeting chooses untried interventions to defeat Ebola. The Lancet 384(9948): e45–e46.

    Article  Google Scholar 

  8. Omonzejele, P.F. 2014. Ethical challenges posed by the Ebola virus epidemic in West Africa. Journal of Bioethical Inquiry 11(4): 417–420.

    Article  PubMed  Google Scholar 

  9. Rid, A., and E.J. Emanuel. 2014. Ethical considerations of experimental interventions in the Ebola outbreak. The Lancet 384(9957): 1896–1899.

    Article  Google Scholar 

  10. World Health Organization [WHO]. 2014. Potential Ebola therapies and vaccines. World Health Organization, November 5. http://apps.who.int/iris/bitstream/10665/137590/1/WHO_EVD_HIS_EMP_14.1_eng.pdf?ua=1. Accessed November 16, 2014.

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Muhammed O. Afolabi.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Afolabi, M.O. Situating the Trovan Trial With the Use of Experimental Ebola Therapies Is Like Comparing an Apple With an Orange. Bioethical Inquiry 12, 19–20 (2015). https://doi.org/10.1007/s11673-015-9619-7

Download citation

Keywords

  • Meningitis
  • Ethical Challenge
  • Trovafloxacin
  • Investigational Agent
  • Meningitic Belt